M&A Deal Summary |
|
---|---|
Date | 2010-10-20 |
Target | Visiogen |
Sector | Medical Products |
Buyer(s) | Abbott Laboratories |
Deal Type | Add-on Acquisition |
Deal Value | 400M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1888 |
Sector | Medical Products |
Employees | 114,000 |
Revenue | 40.1B USD (2023) |
Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 22 of 35 |
Sector (Medical Products) | 10 of 20 |
Type (Add-on Acquisition) | 22 of 35 |
State (California) | 8 of 14 |
Country (United States) | 16 of 27 |
Year (2010) | 4 of 4 |
Size (of disclosed) | 16 of 28 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2010-10-01 |
Abbott Laboratories S.A.
Madrid, Spain Abbott Laboratories, S.A. (Spain) produces solid dose, sterile ointments, oral liquids, aerosols and topical products. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-01-07 |
AbbVie
North Chicago, Illinois, United States AbbVie is a research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address complex and serious diseases. AbbVie's products are focused on treating conditions such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis, and Crohn's disease; low testosterone; HIV; endometriosis; thyroid disease; Parkinson's disease; and complications associated with chronic kidney disease and cystic fibrosis, among other health conditions. AbbVie was founded in 2012 and is based in North Chicago, Illinois. |
Sell | - |